ReviewFrontiers in immunology2021
Using the T Cell Receptor as a Biomarker in Type 1 Diabetes.
Maki Nakayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this papercites it
ReviewFrontiers in immunology2021
Maki Nakayama et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.